Sign In
Free Newsletter
For hospital systems, careful bets on patient population help chart course for future
The state's hospital systems are moving in opposite directions as they strategize how to deal with the final push of Affordable Care Act implementation. And neither strategy is without risk: While some systems could fall behind the reform movement as they wait to see what happens, others may get too far ahead as new models undergo real-world...
FDA approves Bausch Lomb drug
Bausch & Lomb, the Madison-based eye health company, today announced the U.S. Food and Drug Administration has approved the company's new drug application for its Prolensa therapy.
Pay to delay puts Big Pharma, generics in same corner
Pharmaceutical companies and their generic competitors, often courtroom adversaries, are fighting on the same side to protect their right to settle patent disputes out of court through cash payments.
Executives racing to assess how insurance reform will change benefits plans, costs
With time ticking, employers are now grappling with complex — and potentially punitive — rules under the Affordable Care Act, which in 2014 levies fines on employers with 50 or more workers who either don't provide health insurance, or whose employees receive federal subsidies to buy coverage because their employer's plan isn't...
Study reveals populations most in need of health insurance assistance
The expansion of the state's Medicaid program and other Affordable Care Act initiatives will open up health care access to many people, but the state must understand which sociodemographics are most likely to need coverage in order to have a significant impact.
Physicians Foundation awarding 700,000 in grants to help doctors rebuild after Sandy
The Physicians Foundation, a nonprofit organization that seeks to advance the work of practicing physicians and help facilitate the delivery of health care to patients, is providing $700,000 to assist doctors in New Jersey and New York with their rebuilding efforts following the devastation of Hurricane Sandy.
Actavis, Valeant announce marketing deal
Actavis Inc., in Parsippany, announced today it will exclusively market a generic version Zovirax for Valeant Pharmaceuticals International Inc.
J. Knipper acquires InVentive business unit
J. Knipper & Co. Inc., a developer of commercial solutions for the health care industry, announced Wednesday that it acquired the InVentiv Health Mystro sample management and fulfillment business.
Cancer Genetics Inc. announces IPO pricing
Rutherford-based Cancer Genetics Inc., a diagnostics company focused on oncology tests and services, today announced the pricing of its initial public offering of 600,000 shares of its common stock at $10 per share.
Cyclacel announces sale of four patents to Celgene, dismissal of litigation
Cyclacel Pharmaceuticals Inc., in Berkeley Heights, announced today it will sell Celgene Corp., in Summit, four Cyclacel-owned patents in a $5.5 million deal.
Hackensack, Georgetown expand collaboration
Following a physicians’ services agreement launched between Hackensack University Medical Center and MedStar Georgetown University Hospital last month, the entities announced today that the two hospital’s cancer centers will enter an affiliation to bring the newest cancer research to New Jersey.
As execs trade blows, hospitals get the black eye
While a quickly growing number of New Jersey hospitals have for-profit partners or operators, historically, the industry has been nonprofit, and the public's notion that owners are more concerned about bottom lines than health care delivery has been a hard one for these companies to conquer.
